Biotech, Food, Drug

The food we eat and the medicine we put into our bodies are highly regulated by a variety of government agencies. In the United States by the Food and Drug Administration (FDA) and the United States Department of Agriculture (USDA) regulate the processes by which food makes its way to the grocery store and medicine is approved for consumer use.  As the science grows more complex behind the pharmaceutical and food industry, interpretation of the regulations in place is becoming more nuanced.  Overseas, these industries are regulated by a variety of agencies; for example, the Minister of Agriculture in Canada, Centre for Food Safety in Hong Kong, and the Committee of Environmental, Public Health and Food Safety (EU), are among the many governing-bodies which regulate biotechnology, food, and drugs throughout the world.

The National Law Review is your free online resource to agency news, emerging topics in food and drug, and the latest in biotechnology updates. From nanotechnologies being used in research, to regulations of imported foods coming into the US from overseas or the development of medical devices and drugs, readers can find expert legal analysis of the developments in the industry, as well as reports on changes within the agencies that regulate these industries. The National Law Review also covers topics related to licensing, Food Safety and Inspection Services (FSIS), food and beverage regulation in the US and worldwide, nutrition labeling, and country of origin labeling guidelines.

With recent legislation being passed throughout the US in relation to marijuana use, both for recreational and medicinal purposes, readers will also find up-to-date information, litigation, and news coming from this area of interest as well. Regulations in California for labeling and proper sales of marijuana, to use in different states, or internationally, as well as rules for promoting and advertising marijuana are also covered on the site. Additionally, the development and changing landscape of tobacco use to include vaping, and how e-cigarettes and vaping are regulated, is also covered by NLR authors.

Readers who are interested in food safety, inspection, imports into the US, and regulations, these topics are covered regularly on The National Law Review as well. New legislation from the FDA, USDA, Department of Agriculture, and international bodies, are covered on the site. If you are looking for details on new nutrition-labeling regulations or health risks of consuming certain imported foods, you will find these topics, and many more, on The National Law Review.

For hourly updates on the latest news about biotech, food & drug, and cannabis laws, regulations, and legislation, be sure to follow our Cannabis Twitter feed, and sign up for complimentary e-news bulletins.

Custom text Title Organization Sort descending
Feb
26
2019
FDA Finalizes Two Guidance Documents Regarding Regenerative Medicine Therapies Epstein Becker & Green, P.C.
Mar
10
2015
3-D Printing Guidance Only a B-List Priority for FDA Epstein Becker & Green, P.C.
Jan
31
2023
FDA Issues Final and Draft Guidance Documents Regarding Food Allergen Labeling Epstein Becker & Green, P.C.
Aug
29
2019
Will the Growing Acceptance of Cannabis Send Drug-Screening Policies Up in Smoke? Epstein Becker & Green, P.C.
Aug
1
2023
Unpacking Averages: Analyzing the Relationship Between MDRs and Recalls Epstein Becker & Green, P.C.
Sep
12
2023
HHS Recommends Re-Classification of Marijuana as a Schedule III Controlled Substance – A Bellwether for the Future of Cannabis-ness Epstein Becker & Green, P.C.
Mar
24
2020
Medical Marijuana Deemed “Essential” During COVID-19 Pandemic Epstein Becker & Green, P.C.
Mar
8
2024
BioMarin Subpoena Potentially Signals Continued Investigations into Sponsored Testing Programs Epstein Becker & Green, P.C.
Aug
18
2021
Vaccine Mandates, Mandate Bans, Wage and Hour Nomination Stalls – Employment Law This Week [VIDEO] Epstein Becker & Green, P.C.
Jan
13
2022
CMS “Splits the Baby” on Aduhelm—Medicare Coverage but Only with Evidence Development for Now Epstein Becker & Green, P.C.
May
20
2022
The VALID Act: Senate Action Brings FDA Regulation of LDTs Closer to Fruition Epstein Becker & Green, P.C.
Jul
18
2019
Hawaii Decriminalizes Possession of Small Amounts of Marijuana Epstein Becker & Green, P.C.
Jul
24
2015
FDA Leverages Patient-Reported Information to Monitor Drug Safety Epstein Becker & Green, P.C.
Jan
21
2016
No Duty to Accommodate Medical Marijuana Use in New Mexico Epstein Becker & Green, P.C.
May
26
2016
The Scope of FDA’s Proposed Revisions to the IND Regulations May Not Be Sufficient to Achieve Its Stated Goals Epstein Becker & Green, P.C.
Dec
14
2023
President Seeks More Antitrust Scrutiny of Health Care Transactions Epstein Becker & Green, P.C.
Aug
26
2016
New FDA Draft Guidance Shows Limited Compromise with Brand and Generic Drug Manufacturers Epstein Becker & Green, P.C.
Aug
31
2016
FDA Announces November Public Hearing on Off-Label Communications: An Important Step Forward or a Signal that FDA is Headed Back to the Drawing Board? Epstein Becker & Green, P.C.
Aug
18
2017
FDA Makes Moves to Advance Digital Health Epstein Becker & Green, P.C.
Aug
28
2017
NYC OATH Decision Finds for Medical Marijuana User Epstein Becker & Green, P.C.
Sep
18
2017
Federal Laws Do Not Preempt Connecticut Law Providing Employment Protections to Medical Marijuana Users Epstein Becker & Green, P.C.
Jun
4
2021
EEOC Updates Guidance on COVID-19 Vaccination Policies, Including Mandates, Incentives, and Accommodations Epstein Becker & Green, P.C.
Oct
1
2018
FDA Seeks Civil Monetary Penalties Measures to Enforce Compliance with ClinicalTrials.org Requirements Epstein Becker & Green, P.C.
Oct
29
2018
CMS Seeks to Revamp Medicare Part B Drug Reimbursement through Proposed International Pricing Index (IPI) Model Epstein Becker & Green, P.C.
Feb
16
2022
Employers Take Heed: Follow Illinois Biometric Privacy Rules or Risk a Losing Battle Epstein Becker & Green, P.C.
Apr
14
2022
Entrepreneurship in Biotech: Growing Your Business – Diagnosing Health Care [VIDEO] Epstein Becker & Green, P.C.
Feb
14
2019
Remote Prescribing Trends in Telehealth Epstein Becker & Green, P.C.
Jun
23
2022
CMS Reduces COVID-19 Vaccine Mandate Surveys and Rescinds Surveyor Vaccination Requirements Epstein Becker & Green, P.C.
Feb
24
2015
CMS Takes a Measured Approach to Medicare Advantage and Part D Plan Payment Rates and Policy Changes for 2016: Increased Part D Drug Costs Set the Stage for Higher Beneficiary Premiums Epstein Becker & Green, P.C.
Jul
24
2019
New Jersey’s Highest Court to Decide Whether Employers Are Required to Accommodate Medical Marijuana Use Epstein Becker & Green, P.C.
Aug
12
2019
Legislative Efforts to Curb Sexual Harassment in the Hospitality Industry Finally Reach Fruition in Illinois Epstein Becker & Green, P.C.
Aug
24
2023
New York Cannabis Lawsuit Overview and Possible Effects on the Much-Anticipated Adult-Use Cannabis License Application Period Epstein Becker & Green, P.C.
Sep
28
2023
Diagnosing Health Care Podcast – Episode 70: Direct Access Laboratory Testing: Future FDA Proposed Regulations on LDTs [Podcast] Epstein Becker & Green, P.C.
Nov
2
2023
Diagnosing Health Care Podcast – Episode 71: Dietary Supplements – Navigating the Regulatory Maze [Podcast] Epstein Becker & Green, P.C.
Feb
6
2024
Unpacking Averages: Device Manufacturers Should Use the Newly Released Demographic Data in MDRs to Ensure Their Devices Are Not Disproportionately Hurting Minorities Epstein Becker & Green, P.C.
 

NLR Logo

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up to receive our free e-Newsbulletins

 

Sign Up for e-NewsBulletins